These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29983870)

  • 1. Comparative molecular characterization of typical and exceptional responders in glioblastoma.
    Wipfler K; Cornish AS; Guda C
    Oncotarget; 2018 Jun; 9(47):28421-28433. PubMed ID: 29983870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Exceptional or Super Responders to Cancer Drugs.
    Prasad V; Vandross A
    Mayo Clin Proc; 2015 Dec; 90(12):1639-49. PubMed ID: 26546106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
    Wang H; Wang X; Xu L; Zhang J; Cao H
    Front Oncol; 2021; 11():551160. PubMed ID: 33959491
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    Lu J; Cowperthwaite MC; Burnett MG; Shpak M
    PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Profiling of Exceptional Responders to Cancer Therapy.
    Bilusic M; Girardi D; Zhou Y; Jung K; Pei J; Slifker M; Chen Q; Meerzaman D; Alpaugh K; Young D; Flieder D; Gray P; Plimack E
    Oncologist; 2021 Mar; 26(3):186-195. PubMed ID: 33210795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer.
    Kamath S; Roopkumar J; Ni Y; Shen M; Bejarano P; Allende D; Nagarajan A; Nguyen T; Dergham B; Shepard D; Shapiro MA; McNamara MJ; Estfan BN; Nair KG; Khorana AA
    Oncology (Williston Park); 2023 Dec; 37(12):488-495. PubMed ID: 38133563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts.
    Umehara T; Arita H; Yoshioka E; Shofuda T; Kanematsu D; Kinoshita M; Kodama Y; Mano M; Kagawa N; Fujimoto Y; Okita Y; Nonaka M; Nakajo K; Uda T; Tsuyuguchi N; Fukai J; Fujita K; Sakamoto D; Mori K; Kishima H; Kanemura Y
    Acta Neuropathol Commun; 2019 Jun; 7(1):99. PubMed ID: 31215469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway.
    Xiang J; Alafate W; Wu W; Wang Y; Li X; Xie W; Bai X; Li R; Wang M; Wang J
    Cell Death Dis; 2022 Jan; 13(1):58. PubMed ID: 35031599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
    Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
    Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
    Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
    Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
    Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI
    PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma.
    Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J
    Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of sex-dependent gene expression profile in glioblastoma.
    Qin S; Yuan Y; Liu H; Pu Y; Chen K; Wu Y; Su Z
    Neuropathology; 2023 Feb; 43(1):72-83. PubMed ID: 35789505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.